Reprocessed Devices | Market Insights | US | 2023
Despite the short-term challenges posed by the COVID-19 pandemic, the US market for reprocessed device will grow moderately through 2031. This market will be driven by the continuous budget constraints that the healthcare facilities are experiencing and the increasing acceptance rate among physicians for using reprocessed devices. Growth will be particularly strong in the reprocessed EP diagnostic catheter, mainly driven by the high per-unit cost savings associated with reprocessed devices over their OEM counterparts.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for reprocessed devices in the US from 2019 through 2031.
